Jump Trading’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,400
Closed -$154K 508
2018
Q2
$154K Sell
1,400
-1,200
-46% -$128K 0.01% 298
2018
Q1
$278K Buy
2,600
+1,300
+100% +$144K 0.03% 255
2017
Q4
$139K Sell
1,300
-3,500
-73% -$374K 0.02% 319
2017
Q3
$534K Sell
4,800
-24,000
-83% -$2.57M 0.1% 140
2017
Q2
$2.98M Buy
28,800
+24,600
+586% +$2.42M 0.44% 46
2017
Q1
$411K Sell
4,200
-300
-7% -$28.7K 0.13% 95
2016
Q4
$398K Sell
4,500
-11,400
-72% -$1.04M 0.14% 80
2016
Q3
$1.53M Sell
15,900
-49,800
-76% -$4.74M 0.18% 57
2016
Q2
$5.64M Buy
65,700
+65,670
+218,900% +$5.89M 0.25% 43
2016
Q1
$261K Sell
30
-117
-80% -$10.5K 0.01% 491
2015
Q4
$1.66M Buy
+147
New +$16K 0.05% 164
2015
Q3
Sell
-60,600
Closed -$7.45M 679
2015
Q2
$7.45M Buy
60,600
+49,800
+461% +$5.96M 0.14% 43
2015
Q1
$1.24M Buy
10,800
+3,600
+50% +$397K 0.04% 218
2014
Q4
$728K Buy
7,200
+2,700
+60% +$262K 0.02% 380
2014
Q3
$410K Sell
4,500
-72,300
-94% -$6.34M 0.01% 439
2014
Q2
$6.58M Buy
+76,800
New +$6.05M 0.3% 28

Other funds holding IBB

Jump Trading's IBB Position: Q3 2019 in Review

Jump Trading sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 7,361 shares — an estimated $803K sold.

Jump Trading first reported a position in IBB in Q2 2014 and held it in 8 quarters. The position peaked at $5.97M in Q2 2016. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

  • Jump Trading reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
  • Jump Trading sold 7,361 iShares Biotechnology ETF shares in Q3 2019, an estimated $803K.
  • Jump Trading first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 8 quarters.
  • Jump Trading's iShares Biotechnology ETF position peaked at $5.97M in Q2 2016.
  • 597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on Jump Trading's 13F filing for Q3 2019, filed 12 Nov 2019.